cardiac-specific transcription factors such as Gata4 or Nkx2.5 (for a review see 3 ). These cells have been used in several cell therapy approaches aiming at promoting regeneration of damaged hearts (for a review see 4, 5 ). The functional benefits of transplanted CPCs have been mainly ascribed to indirect paracrine mechanisms mediated by secreted factors, as opposed to direct generation of new cardiomyocytes 6, 7 ).
In the context of cardiac progenitor cell proliferation and expansion, a crucial role is played by the Notch signalling pathway, a wellconserved cell-to-cell communication system that critically regulates embryonic heart development. 8, 9 Most specifically, Notch regulates cardiomyocyte proliferation during development and in the early postnatal life. In particular, we and others have shown that the Notch pathway promotes the proliferation of committed precursor cells and immature cardiomyocytes 10, 11 and is essential for the maintenance of the heart structural and functional integrity after damage in mammals as well as in lower vertebrates, 12, 13 in which it has been identified as a central mechanism in heart regeneration. 14, 15 In CPCs, Notch activation prevents premature cardiomyogenic differentiation, while promoting proliferation in transient amplifying populations; 16, 17 conversely, inhibition of the Notch pathway is required to promote cardiac mesoderm differentiation in embryonic stem cells. 18 Committed undifferentiated progenitor cells can be clonally expanded from myocardial biopsy specimens and cultured in vitro as tridimensional spheroids. 19, 20 Cardiospheres (CSps) are cardiac-derived multicellular clusters, considered a reliable in vitro model of the cardiac microenvironment, hosting a reservoir of both immature and committed progenitors towards the three major cardiac cell lineages: cardiomyocytes, endothelial cells (ECs) and smooth muscle cells (SMCs). 21 CSps transplantation into infarcted hearts results in enhanced in vivo cell survival and cardioprotection. 22 Recent data have shown that activation of the Notch signalling pathway promotes cell differentiation along the vascular smooth muscle lineage in CSp-derived cells and is sensitive to oxygen tension in the tridimensional cellular array. 23 In this work, we aimed at dissecting the specific role of Notch1 signalling in CSps. We report that Notch1 stimulation by soluble Jagged-1 triggers a massive increase in both number and size of in vitro cultured CSps. This effect was paralleled by a significant increase in vascular developmental markers such as Flt-1, Kdr and CD31 and the adoption of a specific gene expression signature.
Conversely, the γ-secretase inhibitor, DAPT, which impairs Notch1 activation, effectively blunted in vitro growth of sJ1-stimulated CSps, as well as modulated their gene expression pattern. These effects were further enhanced using Adeno-associated virus (AAV)-based gene transfer of activated Notch1-intracellular domain (N1-ICD) or the soluble-Jagged1 ligand (sJ1) to CSp-forming cells. These viral vectors possess the exquisite capacity to transduce cardiacderived cells at very high efficiency and drive sustained transgene expression. 24, 25 Finally, a whole-genome, synthetic miRNA screening previously conducted in our laboratory has identified a pool of human miRNAs capable of inducing significant proliferation in rodents cardiomyocytes. 26 Notably, the molecular mechanisms by which these miRNAs function in adult cardiomyocytes do not involve reactivation of the Notch pathway. 24 We found that, among all tested miRNAs, hsa-miR-590-3p was the most powerful inducer of a cardiovascular gene expression programme in CSps, leading to a significant increase in both early (Gata4, Nkx2.5) and late cardiac markers (Myh6), as well as of vascular markers (CD31).
Collectively, our results identify Notch1 as a crucial regulator of CSps growth and differentiation along the vascular lineage, raising the possibility that forced activation of this signalling pathway might be exploited to promote in vitro CSps growth not only for therapeutic purposes but also as a tool for evaluating novel cell-free therapeutic strategies (for example, those based on the delivery of exosomes or miRNAs).
| METHODS

| Animals
C57bl/6 and CD1 mice were purchased from Charles River Laborato- 
| Culture of rodent cardiospheres
CSps were obtained and cultured as previously described. 27 Table 2 ) and GoTaq qPCR Mater Mix (Promega, Madison, Wi, USA).
| Immunocytochemical staining
CSps were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton X-100 in phosphate buffered saline (PBS) for 
| Image acquisition and analysis
Images were acquired at room temperature with a DMLB upright fluorescence microscope (Leica, Wetzlar, Germany) equipped with a charge- Within each experiment, instrument settings were kept constant.
| AAV vector production and transduction
The AAV vectors used in this study were generated by the AAV Vector Unit (AVU) at ICGEB Trieste (http://www.icgeb.org/avu-corefacility.html) according to established procedures. All vectors were T A B L E 1 TaqMan real-time PCR assays used to analyse gene expression levels
Notch1 Mm00627185_m1
Jagged1 Mm00496902_m1
Notch2 Mm00803077_m1
Delta-like1 Mm01279269_m1
Hes1 Mm01342805_m1
Hey1 Mm00468865_m1
Hey2 Mm00469280_m1
CD117 Mm00445212_m1
Sca-1 Mm00485928_m1 
| Statistical analysis
All data are presented as mean ± standard error of the mean (SEM).
Statistical analysis was carried out with Prism Software (GraphPad) using one-way ANOVA followed by Bonferroni's post hoc test for comparisons of 3 or more groups. Collectively, these evidences were consistent with the notion that CSps actually represent a valuable in vitro model of early cardiac development.
| RESULTS
|
| Notch signalling components in CSps
To investigate a possible role of the Notch pathway during CSp formation, we analysed the expression levels of the Notch receptors 
| Stimulation of the Notch pathway enhances
CSp growth
In several models of stem cell in vitro culture, Notch expression colocalizes with pools of proliferating cells. 18, 32, 33 To directly assess this issue, we cultured CSps in the presence of the conditioned medium from NIH-3T3 cells secreting a soluble form of Jagged1 (sJ1; 34 ).
In a mirror experiment, we treated cells with the γ-secretase inhibitor, DAPT, to investigate whether blocking Notch activation impairs
CSp formation and growth.
The effect of sJ1 has been extensively characterized in our laboratory. 10, 24, 35 Current evidence suggests that sJ1 may spontaneously cluster on the surface of the target cells by virtue of its interactions with various proteins of the extracellular matrix and cell surface, as described for other soluble growth factors (for a review see [36] [37] [38] ).
sJ1 therefore could activate Notch signalling acting as a soluble cytokine.
Exposure to sJ1 at 3 or 5 days after cell plating significantly boosted the aggregation capacity of CSp-forming cells; however, this effect was blunted when sJ1 was added to cells 7 days after plating. On the other hand, DAPT treatment strongly reduced the number of CSps formed at any time point (Figure 3A, B) . Notch pathway activation showed a remarkable effect not only on the total number of CSps, but also on their size. We also assessed mRNA expression levels for endogenous Notch targets. Gene expression of Hes1 and, to a lesser extent, Hey2 (two major transducers of Notch signalling during heart development) paralleled the increase in CSp growth ( Figure S2 ). We next analysed the expression of genes related to stemness, blood vessel or heart development. Figure 3E shows that sJ1 stimulation markedly increased expression levels of the genes involved in angiogenesis, such as ). A, Representative bright field images of cardiospheres, transduced either with AAV6-MCS, -N1ICD or -sJ1, after 3, 5 and 7 days of in vitro culture. Scale bar: 100 μm. B, Quantification of the number cardiospheres transduced either with AAV6-MCS, -N1ICD or -sJ1, after 3, 5 and 7 days of in vitro culture. Shown are mean ± SEM of at least 3 experimental replicates. C, Distribution of the cross-sectional areas of the cardiospheres, transduced either with AAV6-MCS, -N1ICD or -sJ1, after 3, 5 and 7 days of in vitro culture. Shown are Tukey boxplots. D, Gene expression profile of stem-, vasculo-and cardio-related genes in cardiospheres transduced either with AAV6-MCS, -N1ICD or -sJ1 vectors, at days 3, 5 and 7 after plating. Data are expressed to cellular HPRT mRNA levels. Shown are the mean ± SEM of at least 3 independent experiments. **P < 0.01: *P < 0.05 likely reflected a requirement for sJ1 to accumulate in the extracellular environment in order for the soluble ligand to cluster and activate the Notch pathway. 42, 43 These results further support the peculiar role of the Notch pathway in CSp growth.
To elucidate the gene expression programme activated upon viral transduction, we analysed gene expression of transduced CSps at 3, 5 and 7 days of culture. Both AAV vectors triggered a gene expression programme ( Figure 4D ) superimposable to the one observed upon sJ1 stimulation (cf. Figure 3E) , further supporting the role of Notch1 in the expansion of a pool of cells putatively committed to a cardiovascular fate.
| miR-199a-3p induces Notch expression, while miR-590-3p enhances CSp growth and cardiovascular commitment
A previous whole-genome, synthetic miRNA screening conducted in our laboratory identified several human miRNAs capable of inducing significant proliferation of rodent cardiomyocytes. Of interest, at least two of these miRNAs, miR-199a-3p and miR-590-3p induced cardiac regeneration after myocardial infarction using AAV-mediated gene transfer 26 or delivery of naked miRNA mimics. 44 Notably, the molecular mechanism by which these miRNAs function in adult cardiomyocytes does not involve reactivation of the Notch pathway. 24 We therefore investigated whether the most effective miRNAs in inducing neonatal and adult cardiomyocyte proliferation (hsa-miR-199-3p, hsa-miR-590-3p, hsa-miR-1825, hsamiR-33b-3p) activated the Notch pathway and played functional roles in CSps.
CSp-forming cells were transfected with the miRNAs contextually to plating and analyses were performed after 3, 5 and 7 days of culture. MiR-199a-3p, miR-590-3p and miR-33b-3p triggered a significant rise in the number and size of CSps at all time points. Of note, miR-1825 exerted a unique effect, inducing the formation of a small number of very large CSps ( Figure 5A , B, C). Gene expression analysis revealed increased Notch1 transcript levels as a result of each of the four miRNAs tested, with the highest effect observed using miR199a-3p. This miRNA induced gene overexpression of Notch1 (2.3 fold over control), Jagged1 (2.1 fold over control), Dll-1 (3 fold over control) and Hes1 (4 fold over control) after day 3 of culture (Figure 5D ).
To streamline a common effect of the miRNAs of interest that 
| DISCUSSION
The mammalian heart is unable to compensate for a massive loss of cardiomyocytes after injury. This is due to a dramatic decrease in the proliferative capability of mature cardiomyocytes, compared to neonatal conditions and to the poor regenerative potential of CPCs. Several approaches are under investigation to induce cardiomyocyte proliferation or progenitor activation and expansion.
One of these approaches aims at expanding autologous progenitors cells from minimally invasive cardiac biopsies for cell therapy in patients after myocardial infarction (cf. CADUCEUS phase I trial Clinicaltrials.gov-NCT00893360). This strategy was inspired by a seminal study by E. Messina and co-workers, 19 which established the experimental technique for in vitro growth of progenitor cells isolated from myocardial biopsies. The so-called CSps and CSp-F I G U R E 5 miR-199a induces Notch signalling and enhances cardiosphere growth to a cardio-vascular fate. Cardiosphere-forming cells were transfected contextually to plating with either cel-miR-67 (control), miR-199a-3p, miR-590-3p, miR-1825 or miR-33b-3p. Analyses were performed 3, 5 and 7 days after plating. A, Representative bright field images of cardiospheres, transfected with either celmiR-67 (control), miR-199a-3p, miR-590-3p, miR-1825 or miR-33b-3p, after 3, 5 and 7 days of in vitro culture. Scale bar: 100 μm. B, Quantification of the number of cardiospheres formed upon miRNA transfection, 3, 5 and 7 days of in vitro culture. Shown are mean ± SEM of at least 3 experimental replicates. **P < 0.01: *P < 0.05. C, Distribution of the cross-sectional areas of the cardiospheres, transfected with either celmiR-67 (control), miR-199a-3p, miR-590-3p, miR-1825 or miR-33b-3p, after 3, 5 and 7 days of in vitro culture. Shown are Tukey boxplots. D, Transcription levels of Notch receptors, ligands and the indicated target genes in cardiospheres analysed at day 3, 5 and 7 of culture, following transfection of either cel-miR-67 (control), miR-199a-3p, miR-590-3p, miR-1825 or miR-33b-3p. Data are expressed to cellular HPRT mRNA levels. Shown are the mean ± SEM of at least 3 independent experiments. **P < 0.01: *P < 0.05. E, gene expression analysis of stemness and cardio-vascular markers in cardiospheres analysed after 3 days of culture, following transfection of either cel-miR-67 (control), miR-199a-3p, miR-590-3p, miR-1825 or miR-33b-3p. Data are expressed to cellular HPRT mRNA levels. Shown are the mean ± SEM of at least 3 independent experiments. **P < 0.01: *P < 0.05. F, (a) Representative images of cardiospheres analysed after 3 days of in vitro culture, following transfection of either celmiR-67 (control), miR-199a-3p, miR-590-3p. Gata4 (green), EdU (red), nuclei (blue). Bars: 100 μm. (b) Quantification of Gata4+ and EdU+ cells upon cel-miR-67 (control), miR-199a-3p and miR-590-3p transfection. Shown are mean ± SEM of at least 3 experimental replicates. **P < 0.01: *P < 0.05 derived cells produced using this technique are valuable tools for studying cardiac progenitor cell biology.
Here we have exploited the CSp model to investigate the role of the Notch pathway in the cardiovascular differentiation programme. Previous gene expression studies have shown a phenotypic heterogeneity of the cellular components of CSps. 45, 46 Consistent with these findings, we detected Sca-1 positive cells, along with cells that were more committed towards vasculoendothelial or cardiac fate specification. Previous evidence from our group and other laboratories have demonstrated a peculiar role of the Notch pathway in the expansion of the undifferentiated precursor cell pool in the heart and in the regulation of neonatal cardiomyocyte proliferation both in vitro and in vivo. 10, 12, 16, 29, 30 Given the poorly differentiated molecular signature of the cell components of CSps, we wondered whether Notch signalling was Multiple evidence over the last few years has shown a pivotal role of the microRNA network in the control of most biological functions of heart cells. 47, 48 In particular, a previous whole-genome, synthetic miRNA screening conducted in our laboratory revealed several human miRNAs capable of inducing significant proliferation of neonatal rat and mouse CMs. 26 Among these miRNAs, miR-199a-3p, miR-590-3p and miR-1825, have been shown to be involved in the regulation of embryonic cell proliferation 49 and were capable to induce cardiac regeneration after myocardial infarction (MI), either when expressed using AAV-mediated gene transfer 26 or delivered as naked miRNA mimics. 44 Remarkably, the molecular mechanisms by which the most effective pro-proliferative miRNAs function in adult cardiomyocytes do not involve reactivation of the Notch pathway. 24 We therefore wondered whether they could play a functional role in CSps, acting through multiple, specific pathways. All the miRNAs of interest shared a common effect on CSps, triggering a significant increase in their number and size. Gene expression analysis revealed increased levels of genes of the Notch pathway at the earliest time points of in vitro culture, as a result of each of the four miRNAs tested, suggesting this pathway as a possible target of either direct or indirect regulation by these miRNAs. While the overall mechanism of action of each miRNA is likely different, common pathways are likely to exist. Among Notch signalling negative regulators (GO:0045746), we found several different genes predicted to be differentially downregulated by each of the miRNAs of interest. In particular, we validated as possible targets Neurl1a, a ligand-specific ubiquitin ligase 50, 51 and Dner, coding for a atypical Notch ligand. 28, 52, 53 In both cases, a net downregulation of the transcripts for these genes was observed after expression of all the tested miRNAs.
Collectively, our data show that the Notch pathway drives the proliferation of CSp-forming cells. Exogenous activation of this pathway magnifies these effects and causes a shift of the gene expression profile towards genes involved in cardiovascular differentiation.
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